Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- cDNA cloning of a 30 kDa erythrocyte membrane protein associated with Rh (Rhesus)-blood-group-antigen expression.Biochem J. 1990; 271: 821-825
- Molecular cloning and protein structure of a human blood group Rh polypeptide.Proc Natl Acad Sci U S A. 1990; 87: 6243-6247
- Molecular cloning and primary structure of the human blood group RhD polypeptide.Proc Natl Acad Sci U S A. 1992; 89: 10925-10929
- Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis.Blood. 1991; 78: 2747-2752
- RHD gene deletion occurred in the Rhesus box.Blood. 2000; 95: 3662-3668
- Amniocentesis and chorionic villus sampling.Curr Opin Obstet Gynecol. 2000; 12: 81-86
- Feto-maternal haemorrhage associated with genetic amniocentesis: results of a randomized trial.Br J Obstet Gynaecol. 1987; 94: 528-534
- Presence of fetal DNA in maternal plasma and serum.Lancet. 1997; 350: 485-487
- Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.Am J Hum Genet. 1998; 62: 768-775
- Prenatal typing of RH and Kell blood group system antigens: the edge of a watershed.Transfus Med Rev. 2003; 17: 31-44
- Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma.Clin Chem. 2008; 10: 1664-1672
- Early detection of cell-free fetal DNA in maternal plasma.Early Hum Dev. 2007; 83: 563-566
- Size distribution of maternal and fetal DNA in maternal plasma.Clin Chem. 2004; 50: 88-92
- Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms.Clin Chem. 2004; 50: 1002-1011
- Rapid clearance of fetal DNA from maternal plasma.Am J Hum Genet. 1999; 64: 218-224
- Effect of labor on postpartum clearance of cell-free fetal DNA from the maternal circulation.Prenat Diagn. 2008; 28: 304-308
- Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast.Prenat Diagn. 2007; 27: 415-418
- Circulating fetal DNA in maternal plasma.Clin Chim Acta. 2001; 313: 151-155
- Circulating fetal DNA: its origin and diagnostic potential—a review.Placenta. 2004; 25: S93-101
- To be, or not to be, that is the question. Apoptosis in human trophoblast.Placenta. 2000; 21: 1-13
- Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum.Proc Natl Acad Sci U S A. 1996; 93: 705-708
- Presence of fetal DNA in maternal plasma decades after pregnancy.Hum Genet. 2002; 110: 587-591
- Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer.Blood. 2002; 100: 2845-2851
- Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma.Clin Chem. 2001; 9: 1607-1613
- Human blood groups.2nd edition. Blackwell Science, Oxford2002
- The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in most Africans with the Rh D-negative blood group phenotype.Blood. 2000; 95: 12-18
- Molecular background of VS and weak C expression in blacks.Transfusion. 1997; 37: 38-44
- The Rh VS and V blood group polymorphisms in Africans: a serological and molecular analysis.Transfusion. 1998; 38: 951-958
- Heterogeneous molecular background of the weak C, VS+, hrB, HrB phenotype in black persons.Transfusion. 2009; 49: 495-504
- Molecular background of Rh D-positive, D-negative, Del and weak D phenotypes in Chinese.Vox Sang. 2002; 83: 156-161
- Molecular basis of weak D phenotypes.Blood. 1999; 93: 385-393
- List of D variants.(Available at:) (Accessed December 16, 2009)
- Multiple isoforms excluding normal RhD mRNA detected in Rh blood group Del phenotype with RHD 1227A allele.Transfus Apheresis Sci. 2006; 34: 145-152
- Report of the first international workshop on molecular blood group genotyping.Vox Sang. 2005; 88: 136-142
- Report of the Second International Workshop on molecular blood group genotyping.Vox Sang. 2007; 93: 83-88
- Report of the Third International Workshop on molecular blood group genotyping.Vox Sang. 2009; 96 (Available at:) (Accessed December 16, 2009): 337-343
- The use of maternal plasma for prenatal RhD blood group genotyping.in: Bugert P. DNA and RNA profiling in human blood: methods and protocols. vol. 496. Humana Press, New York2009: 143-157
- Specificity and sensitivity of RHD genotyping methods by PCR-based DNA amplification.Br J Haematol. 1997; 98: 356-364
- Large-scale prediagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women.Mol Diagn. 2004; 8: 23-31
- Non-invasive pre-natal diagnosis and determination of fetal Rh status.Semin Fetal Neonatal Med. 2008; 13: 63-68
- High throughput non-invasive determination of foetal Rhesus D status using automated extraction of cell-free foetal DNA in maternal plasma and mass spectometry.Arch Gynecol Obstet. 2009; 279: 533-537
- Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn.Vox Sang. 2004; 87: 225-232
- Diagnostic accuracy of noninvasive fetal genotyping from maternal blood – a meta analysis.Am J Obstet Gynecol. 2006; 195: 1163-1173
- Non-invasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects.Prenat Diagn. 2009; 29: 101-107
- The SAFE project: towards noninvasive prenatal diagnosis.Biochem Soc Trans. 2009; 37: 460-465
- Brochure from Lenetix.(Available at:) (Accessed December 16, 2009)
- Non-invasive fetal RHD genotyping via real-time PCR of foetal DNA from Chinese RhD-negative maternal plasma.Eur J Clin Invest. 2009; 39: 607-617
- An unusual false positive fetal RHD typing result using DNA derived from maternal plasma from a solid organ recipient.Transfusion. 2006; 46: 1454
- Use of bi-allelic insertion/deletion polymorphisms as a positive control in maternal blood. First clinical experience.Ann N Y Acad Sci. 2006; 1075: 123-129
- RhD genotyping by quantitative fluorescent polymerase chain reaction: a new approach.Br J Obstet Gynaecol. 2000; 107: 1498-1502
- Feasibility study of using fetal DNA in maternal plasma for noninvasive prenatal diagnosis.Acta Obstet Gynecol Scand. 2007; 86: 535-541
- Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis.Clin Chem. 2006; 52: 2211-2218
- Evaluation of noninvasive prenatal RHD genotyping of the fetus.Med J Aust. 2009; 191: 21-25
- Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD®.Transfus Clin Biol. 2007; 14: 572-577
- Fetal RHD genotyping in maternal serum during the first trimester of pregnancy.Br J Haematol. 2002; 119: 255-260
- Prediction of fetal Rh D and Rh CcEe phenotype from maternal plasma with real-time polymerase chain reaction.Transfus Apheresis Sci. 2002; 27: 217-223
- Rh immunization during pregnancy, antenatal prophylaxis.Can Med Assoc J. 1978; 118: 623
- Noninvasive antenatal RHD typing.Transfus Clin Biol. 2006; 13: 53-57
- Effect of high-throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study.Br Med J. 2008; 336: 816-818
- The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.Transfusion. 2008; 48: 2292-2301
- Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin.N Engl J Med. 1999; 340: 1228-1233
- Induction of an inhibitor antibody to factor XI in a patient with severe inherited factor XI deficiency by Rh immune globulin.Blood. 2008; 111: 1306-1308
- Molecular genetic basis of the human Rhesus blood group system.Nat Genet. 1993; 5: 62-65
- DNA-based Rhesus typing: simultaneous determination of RHC and RHD status using the polymerase chain reaction.Vox Sang. 1996; 70: 164-168
- Molecular basis of the Kell (K1) phenotype.Blood. 1995; 85: 912-916
- Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies.J Histochem Cytochem. 2005; 53: 301-305
- Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA from maternal plasma.Transfusion. 2007; 47: 2126-2133
- Preliminary results with fetal Rhc examination in plasma of pregnant women with anti-c.Prenat Diagn. 2008; 28: 335-337
- Noninvasive fetal RhCE genotyping from maternal blood.BJOG. 2009; 116: 144-151
- Short PNA molecular beacons for real-time PCR allelic discrimination of single nucleotide polymorphisms.Mol Cell Probes. 2004; 18: 117-122
- Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectometry.Prenat Diagn. 2008; 28: 203-208
- Blood transfusion in clinical medicine.11th edition. Blackwell, Oxford2005
- Workshop report on the extraction of foetal DNA from maternal plasma.Prenat Diagn. 2007; 27: 824-829
- Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing.BMJ. 2009; 339 (b2451): 161-164
Article info
Publication history
Published online: April 28, 2010
Identification
Copyright
© 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
